154 related articles for article (PubMed ID: 12149659)
1. Effects of efonidipine on platelet and monocyte activation markers in hypertensive patients with and without type 2 diabetes mellitus.
Nomura S; Kanazawa S; Fukuhara S
J Hum Hypertens; 2002 Aug; 16(8):539-47. PubMed ID: 12149659
[TBL] [Abstract][Full Text] [Related]
2. Detection of monocyte-derived microparticles in patients with Type II diabetes mellitus.
Omoto S; Nomura S; Shouzu A; Nishikawa M; Fukuhara S; Iwasaka T
Diabetologia; 2002 Apr; 45(4):550-5. PubMed ID: 12032632
[TBL] [Abstract][Full Text] [Related]
3. Correlation and association between plasma platelet-, monocyte- and endothelial cell-derived microparticles in hypertensive patients with type 2 diabetes mellitus.
Nomura S; Inami N; Shouzu A; Urase F; Maeda Y
Platelets; 2009 Sep; 20(6):406-14. PubMed ID: 19658004
[TBL] [Abstract][Full Text] [Related]
4. Long-term treatment with nifedipine modulates procoagulant marker and C-C chemokine in hypertensive patients with type 2 diabetes mellitus.
Nomura S; Shouzu A; Omoto S; Nishikawa M; Iwasaka T
Thromb Res; 2005; 115(4):277-85. PubMed ID: 15668187
[TBL] [Abstract][Full Text] [Related]
5. Benidipine improves oxidized LDL-dependent monocyte and endothelial dysfunction in hypertensive patients with type 2 diabetes mellitus.
Nomura S; Shouzu A; Omoto S; Nishikawa M; Iwasaka T
J Hum Hypertens; 2005 Jul; 19(7):551-7. PubMed ID: 15829999
[TBL] [Abstract][Full Text] [Related]
6. Effect of valsartan on monocyte/endothelial cell activation markers and adiponectin in hypertensive patients with type 2 diabetes mellitus.
Nomura S; Shouzu A; Omoto S; Nishikawa M; Fukuhara S; Iwasaka T
Thromb Res; 2006; 117(4):385-92. PubMed ID: 15896827
[TBL] [Abstract][Full Text] [Related]
7. Elevation of serum soluble E- and P-selectin in patients with hypertension is reversed by benidipine, a long-acting calcium channel blocker.
Sanada H; Midorikawa S; Yatabe J; Yatabe MS; Katoh T; Baba T; Hashimoto S; Watanabe T
Hypertens Res; 2005 Nov; 28(11):871-8. PubMed ID: 16555575
[TBL] [Abstract][Full Text] [Related]
8. Effects of eicosapentaenoic acid on platelet activation markers and cell adhesion molecules in hyperlipidemic patients with Type 2 diabetes mellitus.
Nomura S; Kanazawa S; Fukuhara S
J Diabetes Complications; 2003; 17(3):153-9. PubMed ID: 12738400
[TBL] [Abstract][Full Text] [Related]
9. Soluble adhesion molecules (sICAM-1, sVCAM-1) and selectins (sE selectin, sP selectin, sL selectin) levels in children and adolescents with obesity, hypertension, and diabetes.
Glowinska B; Urban M; Peczynska J; Florys B
Metabolism; 2005 Aug; 54(8):1020-6. PubMed ID: 16092051
[TBL] [Abstract][Full Text] [Related]
10. Probucol and ticlopidine: effect on platelet and monocyte activation markers in hyperlipidemic patients with and without type 2 diabetes.
Nomura S; Takahashi N; Inami N; Kajiura T; Yamada K; Nakamori H; Tsuda N
Atherosclerosis; 2004 Jun; 174(2):329-35. PubMed ID: 15136063
[TBL] [Abstract][Full Text] [Related]
11. [Platelet activation marker].
Nomura S
Rinsho Byori; 2003 Nov; 51(11):1096-101. PubMed ID: 14679788
[TBL] [Abstract][Full Text] [Related]
12. Platelet activation markers, microparticles and soluble adhesion molecules are elevated in patients with arteriosclerosis obliterans: therapeutic effects by cilostazol and potentiation by dipyridamole.
Nomura S; Inami N; Iwasaka T; Liu Y
Platelets; 2004 May; 15(3):167-72. PubMed ID: 15203718
[TBL] [Abstract][Full Text] [Related]
13. Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels.
Tan KT; Tayebjee MH; Lim HS; Lip GY
Diabet Med; 2005 Dec; 22(12):1657-62. PubMed ID: 16401308
[TBL] [Abstract][Full Text] [Related]
14. Circulating adhesion molecules levels in type 2 diabetes mellitus and hypertension.
Boulbou MS; Koukoulis GN; Makri ED; Petinaki EA; Gourgoulianis KI; Germenis AE
Int J Cardiol; 2005 Jan; 98(1):39-44. PubMed ID: 15676164
[TBL] [Abstract][Full Text] [Related]
15. Effect of nifedipine on adiponectin in hypertensive patients with type 2 diabetes mellitus.
Nomura S; Inami N; Kimura Y; Omoto S; Shouzu A; Nishikawa M; Iwasaka T
J Hum Hypertens; 2007 Jan; 21(1):38-44. PubMed ID: 17051237
[TBL] [Abstract][Full Text] [Related]
16. Significance of microparticles in progressive systemic sclerosis with interstitial pneumonia.
Nomura S; Inami N; Ozaki Y; Kagawa H; Fukuhara S
Platelets; 2008 May; 19(3):192-8. PubMed ID: 18432520
[TBL] [Abstract][Full Text] [Related]
17. The effect of trandolapril and its fixed-dose combination with verapamil on circulating adhesion molecules levels in hypertensive patients with type 2 diabetes.
Rubio-Guerra AF; Vargas-Robles H; Vargas-Ayala G; Rodriguez-Lopez L; Escalante-Acosta BA
Clin Exp Hypertens; 2008 Oct; 30(7):682-8. PubMed ID: 18855271
[TBL] [Abstract][Full Text] [Related]
18. Long-term effect of efonidipine therapy on plasma aldosterone and left ventricular mass index in patients with essential hypertension.
Tsutamoto T; Tanaka T; Nishiyama K; Yamaji M; Kawahara C; Fujii M; Yamamoto T; Horie M
Hypertens Res; 2009 Aug; 32(8):670-4. PubMed ID: 19498438
[TBL] [Abstract][Full Text] [Related]
19. Losartan and simvastatin inhibit platelet activation in hypertensive patients.
Nomura S; Shouzu A; Omoto S; Nishikawa M; Fukuhara S; Iwasaka T
J Thromb Thrombolysis; 2004 Dec; 18(3):177-85. PubMed ID: 15815879
[TBL] [Abstract][Full Text] [Related]
20. [Levels of soluble adhesion molecules among normal and hypertensive type 2 diabetic patients].
Rubio-Guerra AF; Vargas-Robles H; Medina-Santillán R; Escalante-Acosta BA
Gac Med Mex; 2008; 144(1):11-4. PubMed ID: 18619052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
